Cancer Medicines: Uses, Mechanisms And Drug Insights

Cancer Medicine, Treatments & Therapies, Understanding Cancer

May 17, 2026

27 Feb 2026

Targeted Therapy with Larotrectinib in NTRK Fusion Cancers: Results from the NCI-MATCH ECOG-ACRIN Trial

n Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 27, 2026.nnPrecision oncology has transformed cancer ...

Dr. Sophie Reynolds

0 comments

Cancer Medicine, Colorectal Cancer, Treatments & Therapies, Understanding Cancer

May 17, 2026

26 Feb 2026

FDA Gives Full Approval to Encorafenib Combo for BRAF V600E Metastatic Colorectal Cancer

n Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 26, 2026.nnThe US FDA has granted traditional full ap...

Dr. Sophie Reynolds

0 comments

Cancer Medicine, Treatments & Therapies, Understanding Cancer

May 17, 2026

24 Feb 2026

New First-Line Option: FDA Approves Acalabrutinib Combo for CLL/SLL

n Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 24, 2026.nnA new frontline treatment option is now av...

Dr. Sophie Reynolds

0 comments

Cancer Medicine, Skin Cancer, Treatments & Therapies, Understanding Cancer

May 17, 2026

21 Feb 2026

Fixed-Duration Venetoclax vs Continuous Ibrutinib in Untreated CLL: What the CLL17 Trial Means for Patients

n Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 21, 2026.nnChronic lymphocytic leukemia (CLL) is the ...

Dr. Sophie Reynolds

0 comments

Breast Cancer, Cancer Medicine, Treatments & Therapies, Understanding Cancer

May 17, 2026

21 Feb 2026

Does Ribociclib Still Help After 3 Years? The NATALEE Trial’s 4-Year Follow-Up Answers

n Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 21, 2026.nnFor patients with hormone receptor–positiv...

Dr. Sophie Reynolds

0 comments

Breast Cancer, Cancer Medicine, Treatments & Therapies, Understanding Cancer

May 17, 2026

20 Feb 2026

New CDK4/6 Strategies in HR+/HER2– Breast Cancer: Imlunestrant ± Abemaciclib and the Avutometinib Triplet

n Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 20, 2026.nnHormone receptor–positive, HER2-negative (...

Dr. Sophie Reynolds

0 comments

Cancer Medicine, Treatments & Therapies, Understanding Cancer

February 20, 2026

19 Feb 2026

CDK4/6 Inhibitors in Prostate Cancer: What CYCLONE 2 Tells Us About Abemaciclib + Abiraterone

Metastatic castration-resistant prostate cancer (mCRPC) remains one of the most challenging stages of prostate cancer to treat. Althoug...

Dr. Sophie Reynolds

0 comments

Hematology, Blood Cancer, Cancer Medicine

February 10, 2026

10 Feb 2026

What Are Hematologic Malignancies? Types, Causes, and Global Burden

Understanding blood cancers and their impact on global health Hematologic malignancies, commonly known as blood cancers, represent a di...

Skin Cancer Treatment Key things you need to know

Dr. Sophie Reynolds

0 comments

Skin Cancer, Cancer Medicine, Diagnosis and Detection, Uncategorized

February 10, 2026

10 Feb 2026

Skin Cancer: Types, Symptoms, Diagnosis, and Treatment Options

A comprehensive guide to understanding, detecting, and treating skin cancer Skin cancer is the most common form of cancer worldwide, af...

Dr. Sophie Reynolds

0 comments

Cancer Medicine, Colorectal Cancer

February 11, 2026

09 Feb 2026

FDA Approves Breakthrough Liquid Biopsy Test for Advanced Colorectal Cancer Treatment

New diagnostic tool offers hope for personalized treatment of BRAF V600E-mutant metastatic colorectal cancerIn a significant advancemen...